Molecular Mechanisms Underlying Pancreatic Cancer Progression and Drug Resistance
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 215
Special Issue Editors
Interests: pancreatic cancer
Special Issue Information
Dear Colleagues,
Pancreatic ductal adenocarcinoma (PDAC) poses a formidable challenge in oncology due to its high mortality rate, stemming from late detection, rapid metastasis, and resistance to conventional therapies. This Special Issue aims to explore the intricate molecular pathways driving PDAC progression and treatment resistance. Our focus spans various topics, including genetic and epigenetic alterations in tumor initiation and progression, the influence of the tumor microenvironment on cancer aggressiveness, and the molecular mechanisms behind resistance to chemotherapy, immunotherapy, and emerging novel targeted therapies. This issue will also highlight cutting-edge technologies and methodologies such as single-cell sequencing, spatial transcriptomics, and 3D patient tumor avatars (3D-PTAs), which enhance our understanding of PDAC progression and therapeutic resistance. We encourage contributions of original research articles, reviews, and perspectives that illuminate these critical areas to advance our understanding and pave the way for more effective interventions to improve PDAC patient outcomes.
Dr. Daoyan Wei
Prof. Dr. Robert S. Bresalier
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- cancer progression
- therapeutic resistance
- targeted therapies
- oncogenic pathways
- molecular pathogenesis
- tumor heterogeneity
- tumor microenvironment
- precision oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
